• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy A survey of specialized physicians.接受雄激素剥夺治疗的前列腺癌患者代谢、心脏及骨骼健康的筛查与管理：专科医生调查
Can Urol Assoc J. 2024 Jun;18(6):212-215. doi: 10.5489/cuaj.8687.
2
Bone health in men receiving androgen deprivation therapy for prostate cancer.接受前列腺癌雄激素剥夺治疗的男性的骨骼健康
J Urol. 2007 Jan;177(1):17-24. doi: 10.1016/j.juro.2006.08.089.
3
Metabolic changes in patients with prostate cancer during androgen deprivation therapy.前列腺癌患者在雄激素剥夺治疗期间的代谢变化。
Int J Urol. 2018 Jan;25(1):45-53. doi: 10.1111/iju.13473. Epub 2017 Oct 20.
4
Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer.前列腺癌雄激素剥夺治疗的代谢和心血管风险
Expert Rev Endocrinol Metab. 2010 Jul;5(4):531-537. doi: 10.1586/eem.10.35.
5
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.接受雄激素剥夺治疗的前列腺癌患者循环卵泡刺激素水平与身体组成及骨骼健康的关系：BLADE研究
Elife. 2024 Apr 24;13:e92655. doi: 10.7554/eLife.92655.
6
Background to and management of treatment-related bone loss in prostate cancer.前列腺癌治疗相关骨质流失的背景与管理
Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002.
7
Higher serum alkaline phosphatase value indicates the need for bone mineral density testing in non-metastatic prostate cancer patients undergoing androgen deprivation therapy.血清碱性磷酸酶值较高提示行雄激素剥夺治疗的非转移性前列腺癌患者需要进行骨密度检测。
Jpn J Clin Oncol. 2022 Jan 3;52(1):73-80. doi: 10.1093/jjco/hyab147.
8
Short-term impact of androgen deprivation therapy on bone strength in castration-sensitive prostate cancer.去势敏感型前列腺癌患者雄激素剥夺治疗对骨强度的短期影响。
Int J Urol. 2019 Oct;26(10):980-984. doi: 10.1111/iju.14077. Epub 2019 Jul 28.
9
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.雄激素剥夺治疗和雄激素受体抑制剂对非转移性去势抵抗性前列腺癌患者的骨骼健康影响。
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):290-300. doi: 10.1038/s41391-020-00296-y. Epub 2020 Oct 7.
10
A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer.雄激素剥夺疗法（ADT）对前列腺癌男性骨健康状况影响的综述
Endocr Metab Immune Disord Drug Targets. 2017 Nov 16;17(4):276-284. doi: 10.2174/1871530317666170919112757.

引用本文的文献

1
The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer.雄激素剥夺疗法对晚期前列腺癌患者心血管系统的影响。
Medicina (Kaunas). 2024 Oct 22;60(11):1727. doi: 10.3390/medicina60111727.
2
Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: A population-based assessment of adherence to therapeutic monitoring guidelines.接受雄激素剥夺治疗的前列腺癌患者的代谢、心脏和骨骼健康检测：基于人群对治疗监测指南依从性的评估
Cancer. 2025 Jan 1;131(1):e35606. doi: 10.1002/cncr.35606. Epub 2024 Oct 13.

本文引用的文献

1
Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap.泌尿肿瘤学生存指南：证据概述及当前实施差距。
Eur Urol Focus. 2023 May;9(3):431-434. doi: 10.1016/j.euf.2023.02.006. Epub 2023 Feb 25.
2
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.更新——加拿大泌尿外科协会雄激素剥夺治疗指南：不良事件与管理策略
Can Urol Assoc J. 2022 Aug;16(8):E416-E431. doi: 10.5489/cuaj.8054.
3
Optimizing screening and management of cardiovascular health in prostate cancer: A review.前列腺癌心血管健康的筛查与管理优化：综述
Can Urol Assoc J. 2020 Sep;14(9):E458-E464. doi: 10.5489/cuaj.6685.
4
Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation.局限性前列腺癌治疗后的心血管和骨骼相关事件：手术、放疗及雄激素剥夺的作用
Urology. 2016 Nov;97:145-152. doi: 10.1016/j.urology.2016.08.002. Epub 2016 Aug 5.
5
Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.开始雄激素剥夺治疗时使用他汀类药物与激素敏感型前列腺癌进展时间的关系。
JAMA Oncol. 2015 Jul;1(4):495-504. doi: 10.1001/jamaoncol.2015.0829.
6
Adverse effects of androgen deprivation therapy and strategies to mitigate them.雄激素剥夺治疗的不良反应及其缓解策略。
Eur Urol. 2015 May;67(5):825-36. doi: 10.1016/j.eururo.2014.07.010. Epub 2014 Aug 2.
7
Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.二甲双胍的使用与糖尿病男性的全因死亡率和前列腺癌特异性死亡率。
J Clin Oncol. 2013 Sep 1;31(25):3069-75. doi: 10.1200/JCO.2012.46.7043. Epub 2013 Aug 5.
8
What do prostate cancer patients die of?前列腺癌患者死于何种疾病？
Oncologist. 2011;16(2):175-81. doi: 10.1634/theoncologist.2010-0338. Epub 2011 Jan 21.

Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy A survey of specialized physicians.

作者信息

Nguyen David-Dan, Mousa Ahmad, Klotz Laurence, Niazi Tamim, Pouliot Frédéric, Kokorovic Andrea, Lavallée Luke T, Huynh Melissa, Lapointe Nathalie, Di Risio Michelle, Wallis Christopher J D

机构信息

Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.

Division of Urology, Department of Surgery, Sunnybrook Health Sciences, University of Toronto, ON, Canada.

出版信息

Can Urol Assoc J. 2024 Jun;18(6):212-215. doi: 10.5489/cuaj.8687.

DOI:10.5489/cuaj.8687
PMID:38587979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11230694/
Abstract
摘要